Literature DB >> 28969177

Visceral Adiposity Index and the Degree of Hepatic Fibrosis and Inflammation in Egyptian Patients with Chronic Hepatitis C.

Zainab Ahmed Ali-Eldin1, Fatma Ahmed Ali-Eldin2, Inas Elkhedr Mohamed1.   

Abstract

INTRODUCTION: Many clinical studies suggest a direct association between hepatic fat content and visceral adiposity and the progression of fibrosis. AIM: This work aims to clarify the relation between the Visceral Adiposity Index (VAI) and severity of necroinflammatory activity and liver fibrosis in Egyptian patients with chronic Hepatitis C Virus (HCV) infection.
MATERIALS AND METHODS: A cross-sectional study, over a period of six months, was performed on 50 chronic HCV patients subjected to routine laboratory investigations, abdominal ultrasonography, measurement of Waist Circumference (WC), calculation of Body Mass Index (BMI) and VAI, ultrasound guided liver biopsy and assessment of hepatic fibrosis by METAVIR staging.
RESULTS: A total of 50 HCV positive patients, 29 (58%) males and 21 (42%) females were included in the study. Age ranged from 29-60 years (44.4±8.4). BMI was ranged from 20.3 to 41.4 kg/m2 (31.7±5.5). VAI for males was 0.4±0.2 and for females was 0.5±0.3. There were significant positive correlations between VAI and BMI, Triglycerides (TG), fibrosis stages, grades of liver inflammation and FIB-4 Fibrosis-4 score. There were significant negative correlations between VAI and high density lipoprotein, platelets and haemoglobin.
CONCLUSION: There is an association between visceral obesity represented by VAI and the severity of hepatic inflammatory response in chronic hepatitis C patients. Other studies are recommended to measure the clinical implication of visceral obesity on the response to the novel directly acting antivirals.

Entities:  

Keywords:  Liver fibrosis; Viral hepatitis; Visceral obesity

Year:  2017        PMID: 28969177      PMCID: PMC5620818          DOI: 10.7860/JCDR/2017/28381.10330

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  23 in total

1.  Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.

Authors:  Richard K Sterling; Eduardo Lissen; Nathan Clumeck; Ricard Sola; Mendes Cassia Correa; Julio Montaner; Mark S Sulkowski; Francesca J Torriani; Doug T Dieterich; David L Thomas; Diethelm Messinger; Mark Nelson
Journal:  Hepatology       Date:  2006-06       Impact factor: 17.425

2.  Excess visceral adipose tissue/ectopic fat the missing link in the obesity paradox?

Authors:  Jean-Pierre Després
Journal:  J Am Coll Cardiol       Date:  2011-05-10       Impact factor: 24.094

Review 3.  Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss.

Authors:  F H Luyckx; P J Lefebvre; A J Scheen
Journal:  Diabetes Metab       Date:  2000-04       Impact factor: 6.041

4.  Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis.

Authors:  Silvia Mirandola; Stefano Realdon; Jahangir Iqbal; Martina Gerotto; Francesca Dal Pero; Gladis Bortoletto; Moira Marcolongo; Alessandro Vario; Christian Datz; M Mahmood Hussain; Alfredo Alberti
Journal:  Gastroenterology       Date:  2006-03-06       Impact factor: 22.682

5.  Correlation of abdominal fat accumulation and liver steatosis: importance of ultrasonographic and anthropometric measurements.

Authors:  N Sabir; Y Sermez; S Kazil; M Zencir
Journal:  Eur J Ultrasound       Date:  2001-12

6.  Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1.

Authors:  Salvatore Petta; Marco Amato; Daniela Cabibi; Calogero Cammà; Vito Di Marco; Carla Giordano; Aldo Galluzzo; Antonio Craxì
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

7.  Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data.

Authors:  Calogero Cammà; Danilo Di Bona; Filippo Schepis; E Jenny Heathcote; Stefan Zeuzem; Paul J Pockros; Patrick Marcellin; Luis Balart; Alfredo Alberti; Antonio Craxì
Journal:  Hepatology       Date:  2004-02       Impact factor: 17.425

8.  The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.

Authors:  Heather M Patton; Keyur Patel; Cynthia Behling; David Bylund; Lawrence M Blatt; Marc Vallée; Shanon Heaton; Andrew Conrad; Paul J Pockros; John G McHutchison
Journal:  J Hepatol       Date:  2004-03       Impact factor: 25.083

9.  Diagnosis, management, and treatment of hepatitis C: an update.

Authors:  Marc G Ghany; Doris B Strader; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

Review 10.  Steatosis and hepatitis C.

Authors:  Jamak Modaresi Esfeh; Kianoush Ansari-Gilani
Journal:  Gastroenterol Rep (Oxf)       Date:  2015-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.